Guillain-Barre Syndrome
Lancet 366:1653-1666, Hughes,R.C. &Comblath,D.R., 2005
Using Functional Magnetic Resonance Imaging to detect Covert Awareness in the Vegetative State
Arch Neurol 64:1098-1102, Owen,A.M.,et al, 2007
10 Questions About the Clinical Determination of Brain Death
Neurologist 13:380-381, Wijdicks,E.F.M., 2007
Neurologic Patient Safety: An In-Depth Study of Malpractice Claims
Neurol 65:1284-1286, Glick,T.H.,et al, 2005
Clinical Features and Diagnosis of Primary Central Nervous System Lymphoma
Hematol Oncol Clin North Am 19:689-703, Fitzsimmons,A.,et al, 2005
Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease
Arch Neurol 60:813-816,803, Geschwind,M.D.,et al, 2003
Clinical Carotid Endarterectomy Decision Making
Neurol 56:1009-1015,990, Johnston,D.C.C. & Goldstein,L.B., 2001
Inborn Errors of Metabolism as a Cause of Neurological Disease in Adults: An Approach to Investigation
JNNP 69: 5-12, Gray,R.G.F. et al, 2000